Stay updated with breaking news from Eric Elenko. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Karuna Therapeutics (NASDAQ:KRTX – Get Rating) had its price target cut by HC Wainwright from $320.00 to $300.00 in a report issued on Tuesday morning, The Fly reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Karuna Therapeutics’ Q1 2023 earnings at ($2.61) EPS, Q2 2023 earnings at […]
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) – Equities research analysts at HC Wainwright upped their Q1 2023 earnings estimates for shares of Karuna Therapeutics in a report issued on Tuesday, March 28th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings of ($2.61) per share for the quarter, up from […]
Moody Aldrich Partners LLC raised its holdings in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) by 18.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 18,055 shares of the company’s stock after buying an additional 2,816 shares during the […]
Karuna Therapeutics (NASDAQ:KRTX – Get Rating) had its price objective cut by analysts at HC Wainwright from $320.00 to $300.00 in a note issued to investors on Tuesday, The Fly reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s target price indicates a potential upside of 66.09% from the stock’s previous […]
Catalyst Private Wealth LLC grew its stake in Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) by 50.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 21,837 shares of the company’s stock after acquiring an additional 7,361 shares during the quarter. Karuna Therapeutics comprises […]